FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Cantrell Drug Adenosine in 0 Recall

Adenosine in 0

Cantrell Drug Company · Little Rock, AR

Risk level
Class II
Reported by FDA
Aug 16, 2017
Recall ID
D-1076-2017
Check your lot numberHow we source this data

Summary

Cantrell Drug recalled Adenosine in 0 starting Jul 14, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1076-2017 on Aug 16, 2017. Reason: Lack of Sterility Assurance. Status: Terminated.

Why it was recalled

Lack of Sterility Assurance.

Product description

Adenosine in 0.9% Sodium Chloride 30mL, 90 mg/30 mL (3 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd. Little Rock, AR 72207 877-666-5222; NDC 52533-236-03

Lot numbers, UPCs & expiration codes

Lot #: 9814, 9831 BUD: 9/12/2017; 10059, BUD: 10/18/2017

Where it was sold

Nationwide within the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1076-2017
Classification
Class II
Status
Terminated
Recall initiated
Jul 14, 2017
FDA report date
Aug 16, 2017
Quantity
6210 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Cantrell Drug Company

Original FDA data

Every field from FDA enforcement report D-1076-2017, exactly as published.

Show all FDA fields
City
Little Rock
State
AR
Status
Terminated
Country
United States
Event ID
77780
Address
7321 Cantrell Rd
Code information
Lot #: 9814, 9831 BUD: 9/12/2017; 10059, BUD: 10/18/2017
Postal code
72207-4144
Report date
Aug 16, 2017
Product type
Drugs
Recall number
D-1076-2017
Classification
Class II
Recalling firm
Cantrell Drug Company
Product quantity
6210 syringes
Termination date
Sep 16, 2020
Reason for recall
Lack of Sterility Assurance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Adenosine in 0.9% Sodium Chloride 30mL, 90 mg/30 mL (3 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd. Little Rock, AR 72207 877-666-5222; NDC 52533-236-03
Distribution pattern
Nationwide within the US
Recall initiation date
Jul 14, 2017
Initial firm notification
Letter
Center classification date
Aug 9, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1076-2017, published Aug 16, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls